Stocks surge to start week | Dimon says JPMorgan 'very valuable' | New high this year?
EDITOR'S NOTE
The market surged on Tuesday as investors continued to predict success in reopening the economy and developing a Covid-19 vaccine.
The S&P 500 and Dow Jones Industrial Average briefly crossed psychologically important barriers of 3,000 on the S&P and 25,000 on the Dow before closing slightly below those milestones.
Most significantly, the S&P briefly eclipsed its 200-day moving average - a technical signal that historically has drawn more investors into the market, writes CNBC's Patti Domm.
Investors will be watching this week whether the market can take back those key milestones and stay above them. Investors appeared emboldened by yet another positive headline in the race to develop a coronavirus cure, with Novavax announcing a human study of its experimental vaccine.
Another positive sign for the market was an unexpected improvement in consumer confidence. "The gradual re-opening of the economy helped improve consumers' spirits," said Lynn Franco of The Conference Board.
"The virus appears to be coming under control," wrote Bruce Bittles, chief investment strategist at Baird. "Lockdowns have been relaxed and we have not seen a resurgence in the virus."
Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world. TOP NEWS
TOP VIDEO
CNBC PRO
SPECIAL REPORTS
|
Post a Comment